BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33465778
Number of visits today
2667
Number of downloads
16647294
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Wu A, Lim M. The Challenges and Future of Immunotherapy for Gliomas. Cancer J 2021;27:371-8. [PMID: 34570451 DOI: 10.1097/PPO.0000000000000544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Huang X, Shi S, Wang H, Zhao T, Wang Y, Huang S, Su Y, Zhao C, Yang M. Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas. International Immunopharmacology 2023;117:109990. [DOI: 10.1016/j.intimp.2023.109990] [Reference Citation Analysis]
2 Willman M, Willman J, Figg J, Dioso E, Sriram S, Olowofela B, Chacko K, Hernandez J, Lucke-Wold B. Update for astrocytomas: medical and surgical management considerations. Explor Neurosci 2023;2:1-26. [PMID: 36935776 DOI: 10.37349/en.2023.00009] [Reference Citation Analysis]
3 Zhang S, Xiao X, Wang Y, Song T, Li C, Bao H, Liu Q, Sun G, Sun X, Su T, Fu T, Wang Y, Liang P. Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma. Front Genet 2022;13:899125. [DOI: 10.3389/fgene.2022.899125] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345